Social engagement
Social engagement: 427 social following, 3 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Accelerator & incubator | 1 | 33% |
Developer of oral immunotherapies for treating food allergies
Social engagement: 427 social following, 3 posts in the last 12 months — below the industry typical range.
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 67% |
| Accelerator & incubator | 1 | 33% |